Future

KromaTiD is early in development of product applications of its technology but has achieved significant proof of concept milestones. KromaTiD will continue to seek non-dilutive financing but is open to strategic investment that enables more rapid development of its technology platform, either for specific applications it is already pursuing or customized to the commercialization interests of a partner in the molecular diagnostics field.